IDEXX LABORATORIES INC /DE

IDXXNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$4.3B

▲ 10.4% YoY

Net Income

$1.1B

▲ 19.3% YoY

EPS

$13.08

▲ 22.6% YoY

Cash

$180.1M

▼ 37.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.